Coronavirus Research To Resume In US With Stricter Rules

WASHINGTON, DC (IANS) – The US National Institutes of Health (NIH) has reinstated a grant to New York City-based nonprofit Eco Health Alliance to resume controversial research on bat coronaviruses, albeit with stricter restrictions, according to a report by the journal Nature.

Eco Health Alliance had, in 2020, lost the funding to study how coronaviruses such as SARS-CoV-2 jump from bats to humans for its collaborations with the Wuhan Institute of Virology in China.

The Donald Trump administration in April 2020, hinted that the SARS-CoV-2, which caused Covid-19 pandemic, originated in the infamous WIV laboratory.

However, the new 4-year, $2.9 million award comes with an extensive list of restrictions.

The rules forbid Eco Health from “performing any in-country research in China, including with the WIV, or collecting any new samples from vertebrates — such as bats”, the report said.

The NIH will also scrutinize Eco Health’s “finances and accounting practices”, as a federal watchdog report in January claimed to find that the non-profit had misreported about $90,000 in expenses.

“In addition, Eco-Health will be forbidden from performing any work that is deemed by the NIH’s parent organization, the US Department of Health and Human Services, to have the potential to enhance the virulence or transmission of a virus,” the report said.

According to experts, such research is essential for developing vaccines and therapeutics against emerging pathogens and to avert the next pandemic.

“I don’t know if any other single grantee from NIH has been subjected to this level of oversight,” Peter Daszak, President of EcoHealth Alliance was quoted as saying.

The organization has nearly 300 partial or complete genomes of SARS-related coronaviruses from samples collected prior to the funding halt, which will be a key priority to analyze using the newly released grant funds, he said.

According to Angela Rasmussen, a virologist at the University of Saskatchewan in Saskatoon, Canada, it is a pleasant surprise to see the grant renewed. She, however, worries about the “terrible precedent” that the NIH has set by “arbitrarily” terminating an award based on “unfounded rumors” regarding the origins of SARS-CoV-2, the report said.

Rasmussen said she hopes that these restrictions will not apply to other scientists doing similar work.